Our recent application for the MIT-Haalbaarheid was successful. This provides Kaminari Medical with 20k to support our feasibility activities.
Author: haleykaminari
Semi-finalist: EIT Health Catapult 2021
Kaminari Medical is one of 42 start-ups selected from across Europe for the EIT Health Catapult Semi-finals.
We look forward to the training from experts and meeting with investors and corporates.
Semi Finals Pitch: December 2nd 2021
Early stage investor Uniiq, invests in Kaminari Medical
Uniiq, the South Holland investment fund has invested €300,000 in Kaminari Medical for the further development of our imaging technology .
Jeroen Kodde, CEO of Kaminari Medical: “The investment from UNIIQ makes it possible for us to further develop our catheter for eventual use in patients. We have shown in the laboratory that the system works and we are now taking steps to improve the detection of these high-risk plaques in the clinic and, of course, their treatment.”
Take-off phase 2 from NWO awarded
Kaminari Medical successfully attained 250k for the Take-off 2 funding for early phase projects from The Dutch Research Council (NWO) .
Momentum fund closure supports Kaminari Medical
NLC -The European Healthtech Venture Builder has closed Momentum – a € 2.2 mln fund for private investments -within a month. This fund will be invested in 11 innovative healthtech ventures from NLC’s portfolio including Kaminari Medical. With this new way of funding, investors can easily spread their money and hence their risk, and at the same time build up a broad portfolio of startups.
EIT Headstart funding granted
Kaminari Medical was granted the EIT Headstart funding of €50k from EIT Health.
NWO Take-off 1 granted for feasibility study
Kaminari Medical was granted Take-off 1 €40k from The Dutch Research Council (NWO) to complete a feasibility study on the commercial application of the IVPA technology.
